NEJM Catalyst Insights Council members say that while transparency might be necessary, we have to change the way care is delivered.
Efforts to mitigate rising health care costs have left most industry participants — patients, providers, and payers alike — frustrated at the lack of progress. While there is plenty of blame to go around, a significant open question remains: how responsible are patients for reducing costs?
John P. Andrawis, Mark McClellan & Kevin J. Bozic
Dell Medical School at The University of Texas at Austin has improved outcomes and reduced costs for musculoskeletal care with a multidisciplinary Musculoskeletal Institute and bundled payment model.
David Lansky & Jeff Micklos
Care management should be payer-agnostic at its core.
JP Sharp, Patrick H. Conway & Rahul Rajkumar
We believe North Carolina can be a model for the nation.
Nicholas Bagley, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern
Three proposals for improving the law to reflect 21st-century drug development practices.
Dana P. Goldman, Karen Van Nuys, Wei-Han Cheng, Jakub P. Hlávka, Luca Pani, Sylvain Chassang & Erik Snowberg
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.
Case Study by
John Grady-Benson, Michael Cremins, Elizabeth Olson, Nishwant Swami & Steven Schutzer
The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.
Case Study by
Patrick Cronin, Shailesh Dominic Aranha & Alexa Boer Kimball
Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.
NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.